Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kadar

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Studies in Hematology and Blood Transfusion|January 1, 1990
The current status of low-density lipoprotein apheresisH Borberg, J Kadar, K Oette
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1987
[Side effects and risks in cytapheresis donors]H Borberg, A Gaczkowski, J Kadar, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1991
[Therapeutic cytapheresis]D Wiebecke, U Gunzer, H Ullrich, et al.
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensionsA Trummer, J Kadar, L Arseniev, et al.
Acta Medica Austriaca|January 1, 1991
Erythrocyte apheresis in combination with elimination of fibrinogen and plasma proteins of higher molecular weight in macular disease and in uveal effusion syndromeR Brunner, H Borberg, J Kadar, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1988
[Modification of hemorrheologic and laboratory chemical parameters by infusion therapy and preserved serum and by plasma exchange with human albumin and preserved serum in patients with posterior and intermediate uveitis]M Jahn, R Brunner, H Borberg, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
Biocompatibility studies of the single-needle technique in plateletpheresis with the Fresenius AS 104 blood cell separatorR Moog, J Kadar, N Müller, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Therapeutic thrombocytapheresis in patients with myeloproliferative diseases with the cell separators Fresenius AS 104 and Cobe Spectra: biocompatibility and safety]H Ullrich, J Kadar, Y Waxenberger, et al.
Developments in Ophthalmology|January 1, 1992
Plasma exchange and immunoglobulins in the treatment of intermediate uveitisR Brunner, H Borberg, J Kadar, et al.
British Journal of Haematology|April 8, 1998
Sustained decrease of peripheral lymphocytes after allogeneic blood stem cell apheresesJ Novotny, J Kadar, B Hertenstein, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Studies in Hematology and Blood Transfusion|January 1, 1990
The current status of low-density lipoprotein apheresisH Borberg, J Kadar, K Oette
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1987
[Side effects and risks in cytapheresis donors]H Borberg, A Gaczkowski, J Kadar, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1991
[Therapeutic cytapheresis]D Wiebecke, U Gunzer, H Ullrich, et al.
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensionsA Trummer, J Kadar, L Arseniev, et al.
Acta Medica Austriaca|January 1, 1991
Erythrocyte apheresis in combination with elimination of fibrinogen and plasma proteins of higher molecular weight in macular disease and in uveal effusion syndromeR Brunner, H Borberg, J Kadar, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1988
[Modification of hemorrheologic and laboratory chemical parameters by infusion therapy and preserved serum and by plasma exchange with human albumin and preserved serum in patients with posterior and intermediate uveitis]M Jahn, R Brunner, H Borberg, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
Biocompatibility studies of the single-needle technique in plateletpheresis with the Fresenius AS 104 blood cell separatorR Moog, J Kadar, N Müller, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Therapeutic thrombocytapheresis in patients with myeloproliferative diseases with the cell separators Fresenius AS 104 and Cobe Spectra: biocompatibility and safety]H Ullrich, J Kadar, Y Waxenberger, et al.
Developments in Ophthalmology|January 1, 1992
Plasma exchange and immunoglobulins in the treatment of intermediate uveitisR Brunner, H Borberg, J Kadar, et al.
British Journal of Haematology|April 8, 1998
Sustained decrease of peripheral lymphocytes after allogeneic blood stem cell apheresesJ Novotny, J Kadar, B Hertenstein, et al.
Pageof 2